SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $287,891,952 |
| Positions | 16 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| MAPLIGHT THERAPEUTICS INC | MPLT | COM | $34,048,394 | 950,011 |
| TYRA BIOSCIENCES INC | TYRA | COM | $32,875,778 | 1,029,298 |
| ENTRADA THERAPEUTICS INC | TRDA | COM | $29,854,949 | 4,056,379 |
| PHARVARIS N V | PHVS | COM | $27,581,008 | 797,600 |
| CAMP4 THERAPEUTICS CORP | CAMP | COM | $25,647,928 | 5,869,091 |
| ARTIVA BIOTHERAPEUTICS INC | ARTV | COM | $22,827,049 | 2,353,304 |
| TECTONIC THERAPEUTIC INC | TECX | COM | $20,853,938 | 606,660 |
| ZENTALIS PHARMACEUTICALS INC | ZNTL | COM | $19,147,378 | 3,947,913 |
| CELLDEX THERAPEUTICS INC NEW | CLDX | COM NEW | $18,503,417 | 497,270 |
| EYEPOINT INC | EYPT | COM NEW | $15,015,000 | 1,050,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.